Skip to Main Content

Paper Details

Serine peptidase inhibitor Kazal type 1 (SPINK1) as novel downstream effector of the cadherin-17/β-catenin axis in hepatocellular carcinoma.
Cellular oncology (Dordrecht)
11
2017
-, -catenin, /, CDH17, ERK, HCC, HCC cells, HCCs, Hepatocellular carcinoma, MEK, SPINK1, Serine, Serine peptidase inhibitor Kazal type 1, c-Raf, cadherin, cadherin-17, catenin, hepatocellular carcinoma, human, liver cancer, luciferase reporter, patients, primary human HCCs, tumor, tumors
Author NameAffiliation
Wing-Kin SungNational University of Singapore
Wing-Kin SungGenome Institute of Singapore
  • 1 - 2

Datasets

Release 1.2